TY - JOUR
T1 - Physical activity, health-related fitness, and physical performance in children with acquired hypothalamic dysfunction
AU - Van Roessel, I. M.A.A.
AU - Van Schaik, J.
AU - Kleinlugtenbelt, L. B.
AU - van Duijn, S. N.
AU - Burghard, M.
AU - Takken, T.
AU - Tissing, W. J.E.
AU - Bekkering, W. P.
AU - van Santen, H. M.
N1 - © 2025. The Author(s).
PY - 2025/3/18
Y1 - 2025/3/18
N2 - Purpose: Survivors of a pediatric suprasellar tumor may suffer from hypothalamic-pituitary dysfunction (HD), which may result in hypothalamic obesity (HO). The first step in HO treatment is lifestyle intervention (e.g. exercise). Our aim was to assess physical activity (PA), health-related fitness (HRF) and physical performance (PP) in a cohort of children with a suprasellar tumor. Methods: Retrospective study on a national cohort including all children with a suprasellar tumor who were referred to the physiotherapy department 2018—2022. Data was collected on: PA defined as minutes of Moderate-to-Vigorous Physical Activity (MVPA) and number of steps per day, HRF defined as body composition, VO2peak percentage of predicted, mean power, and muscle strength, and PP based on the 10-m walk and run test, time up and down the stairs, and time to rise from the floor. Results: Seventy-three children (mean age 11.09, mean body mass index SDS 2.36) were evaluated. In total, 24.1% reached the guideline of ≥ 60 min MVPA per day. The VO2peak percentage of predicted was 71.0% [IQR 57.0 – 82.8] and in 58.3% mean power was ≤ -2 SDS. Muscle strength was not decreased (median of -0.5 SDS). PP was found to be better than the norm. Conclusion and key findings: PA and HRF are decreased in children with HD, however PP was not decreased. This implies that no PP restrictions are present to engage in PA and that a lifestyle coach can be involved to improve PA and HRF in these children.
AB - Purpose: Survivors of a pediatric suprasellar tumor may suffer from hypothalamic-pituitary dysfunction (HD), which may result in hypothalamic obesity (HO). The first step in HO treatment is lifestyle intervention (e.g. exercise). Our aim was to assess physical activity (PA), health-related fitness (HRF) and physical performance (PP) in a cohort of children with a suprasellar tumor. Methods: Retrospective study on a national cohort including all children with a suprasellar tumor who were referred to the physiotherapy department 2018—2022. Data was collected on: PA defined as minutes of Moderate-to-Vigorous Physical Activity (MVPA) and number of steps per day, HRF defined as body composition, VO2peak percentage of predicted, mean power, and muscle strength, and PP based on the 10-m walk and run test, time up and down the stairs, and time to rise from the floor. Results: Seventy-three children (mean age 11.09, mean body mass index SDS 2.36) were evaluated. In total, 24.1% reached the guideline of ≥ 60 min MVPA per day. The VO2peak percentage of predicted was 71.0% [IQR 57.0 – 82.8] and in 58.3% mean power was ≤ -2 SDS. Muscle strength was not decreased (median of -0.5 SDS). PP was found to be better than the norm. Conclusion and key findings: PA and HRF are decreased in children with HD, however PP was not decreased. This implies that no PP restrictions are present to engage in PA and that a lifestyle coach can be involved to improve PA and HRF in these children.
KW - Cardiorespiratory fitness
KW - Childhood brain tumor survivors
KW - Hypothalamic-pituitary dysfunction
KW - Lifestyle
KW - Physiotherapy
KW - Physical Fitness/physiology
KW - Humans
KW - Muscle Strength/physiology
KW - Exercise/physiology
KW - Male
KW - Hypothalamic Diseases/etiology
KW - Adolescent
KW - Female
KW - Retrospective Studies
KW - Physical Functional Performance
KW - Child
UR - https://www.scopus.com/pages/publications/105000413507
UR - https://www.mendeley.com/catalogue/a82b99a4-40b4-30ae-955b-baf94a68e682/
U2 - 10.1007/s00520-025-09361-5
DO - 10.1007/s00520-025-09361-5
M3 - Article
C2 - 40100427
AN - SCOPUS:105000413507
SN - 0941-4355
VL - 33
JO - Supportive Care in Cancer
JF - Supportive Care in Cancer
IS - 4
M1 - 295
ER -